about
Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralizationZika Virus: New Clinical Syndromes and Its Emergence in the Western HemisphereA Mouse Model of Zika Virus PathogenesisPreparing for the Next Epidemic with Basic VirologyCastanospermine, a potent inhibitor of dengue virus infection in vitro and in vivoUtilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya InfectionChikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoesA CRISPR screen defines a signal peptide processing pathway required by flavivirusesFeasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplexActively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA.Mechanisms of Zika Virus Infection and NeuropathogenesisThe interferon-stimulated gene IFITM3 restricts West Nile virus infection and pathogenesisBroadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral SerotypeModeling Zika Virus Infection in PregnancyMolecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease ControlAn ultrasensitive electrogenerated chemiluminescence-based immunoassay for specific detection of Zika virusThe Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific MannerThe 5' and 3' ends of alphavirus RNAs--Non-coding is not non-functionalInterferon-λ: Immune Functions at Barrier Surfaces and BeyondDegrees of maturity: the complex structure and biology of flavivirusesDengue Virus Immunopathogenesis: Lessons Applicable to the Emergence of Zika VirusLoss of DAP12 and FcRγ drives exaggerated IL-12 production and CD8(+) T cell response by CCR2(+) Mo-DCsExperimental infection of rhesus macaques and common marmosets with a European strain of West Nile virusLethal antibody enhancement of dengue disease in mice is prevented by Fc modificationAge-Dependent Cell Trafficking Defects in Draining Lymph Nodes Impair Adaptive Immunity and Control of West Nile Virus InfectionVaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virusDevelopment of a highly protective combination monoclonal antibody therapy against Chikungunya virusZika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in TearsComplement activation is required for induction of a protective antibody response against West Nile virus infectionNeuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survivalProtective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virusCD8+ T Cells Require Perforin To Clear West Nile Virus from Infected NeuronsAntibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent MechanismsCleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinaseB cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.Development of a humanized monoclonal antibody with therapeutic potential against West Nile virusGamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus InfectionPKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in NeuronsWest Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody
P50
Q21128795-D642D411-63F3-401F-9341-65B87D8EE2C3Q24261248-E401091C-ACD8-4904-8BBC-9CCD2FF16AB2Q24261408-418F6E25-8878-44F4-8246-CC6E6227A2EDQ24282611-20DB15EF-353C-43AC-9335-8C7701202C25Q24531947-0F60D8F4-BDE8-44E6-B4EB-8BC96B3C2508Q24701740-1F6BCF7A-87E3-4CF1-B961-0983CC94031AQ24701786-0C0B9CC1-EC69-43B5-B90F-668B2F4C6854Q24705237-AB45EB09-A9E1-40BD-87B9-FB4F24E1B151Q24737461-DCECA53D-AA3D-49A8-ACE8-AF4DC0085439Q24816212-ACF6C557-AD00-45C5-AB92-768070092CF2Q25019713-2625E3EA-94B5-4B44-B888-C504CA661C51Q25708087-8FED0E7D-D4E9-446C-B994-29AC3985D844Q26252060-160E9229-E8A2-4B3A-8E59-A4BC2D3FA854Q26252516-93DF14EA-D742-440D-A7DE-B646401DA6D5Q26314452-9081E11C-A5F6-43B5-B32D-50766EB88C33Q26694337-019ADF4D-CA7C-409F-B647-6343368088F4Q26700088-1E4F04F2-BE3C-4AE4-B370-B846B96F6C90Q26700110-78664225-7DA2-4132-A577-E59D14B9A33CQ26801049-0C557DA1-AC8A-4BA4-8D53-9432C0546160Q26824712-F236BE8C-41CB-4B4C-B67A-55F9799530FFQ27010600-C2C78149-33D4-44AC-9B6C-1B7D7E0028F5Q27304838-0592DE2A-150D-40FC-8B78-E8B14636ECC3Q27304916-0E3D0DBA-38C0-4541-A3C5-B071C8BCFA23Q27315772-6EB8EC95-2B27-417D-B10E-35C9A33041ABQ27318656-0DA6FE5B-204F-44C5-974E-58EE51DC17BDQ27329490-906D95E8-F7A5-4657-A590-E60F0F7A0A35Q27335008-D76E0887-EFE0-424B-AF2A-25484AA330C5Q27468757-F34AACFD-43BA-4CD3-AD61-5D6C7D6C8449Q27469834-068E15B4-9428-46D5-9251-36271D3CCAECQ27470828-55E6A0FA-3B82-436B-9B53-82244E46CE30Q27472671-04F75CBA-55DF-4833-8904-29661F366D70Q27472711-34140A1B-069D-4958-9A6C-FA685E9844A1Q27472780-5F20FDD0-6AF9-404E-A3BE-8FD0FF4A6D6AQ27472823-4F14F0BB-AEC2-4FAA-86F5-15D0F51984E0Q27472859-90BFFA2E-3B87-4CDE-81C1-DE58388DA506Q27473103-A985CC21-71B8-4A2F-A6CF-78C0B7517825Q27473186-1287642D-7BB1-46E9-85FB-E2818245F6BCQ27473224-4BA56169-74CD-45C5-A377-B2F52AFCDFA3Q27473291-0FDF009B-91C1-4434-AFC5-E512A62EA29FQ27477479-3407CB2C-1B35-440A-9DBC-FED4816F46D3
P50
description
dokter
@id
medico
@it
physician
@en
virolog
@da
name
Michael S. Diamond
@ast
Michael S. Diamond
@da
Michael S. Diamond
@de
Michael S. Diamond
@en
Michael S. Diamond
@es
Michael S. Diamond
@fo
Michael S. Diamond
@fr
Michael S. Diamond
@is
Michael S. Diamond
@kl
Michael S. Diamond
@nb
type
label
Michael S. Diamond
@ast
Michael S. Diamond
@da
Michael S. Diamond
@de
Michael S. Diamond
@en
Michael S. Diamond
@es
Michael S. Diamond
@fo
Michael S. Diamond
@fr
Michael S. Diamond
@is
Michael S. Diamond
@kl
Michael S. Diamond
@nb
altLabel
M Diamond
@en
M S Diamond
@en
M. Diamond
@en
M. S. Diamond
@en
Michael Diamond
@en
Michael S Diamond
@en
prefLabel
Michael S. Diamond
@ast
Michael S. Diamond
@da
Michael S. Diamond
@de
Michael S. Diamond
@en
Michael S. Diamond
@es
Michael S. Diamond
@fo
Michael S. Diamond
@fr
Michael S. Diamond
@is
Michael S. Diamond
@kl
Michael S. Diamond
@nb
P1006
P214
P244
P1006
P101
P106
P21
P213
0000 0000 7376 1346
P214
P244
n2008181135
P31
P496
0000-0002-6646-6781
0000-0002-8791-3165
P6023
P734
P735
P7859
lccn-n2008181135